Back to Search
FREDERICK SCHNELL, M.D.
M.D.
Radiation Oncology Physician
NPI: 1487638607IndividualAccepts Medicare
Specialties, Licenses & Credentials
Specialist
Specialist
Code: 174400000X
042424(GA)
Radiation Oncology PhysicianPrimary
Radiology — Radiation Oncology
Code: 2085R0001X
MD.19982(AL)042424(GA)
CMS Specialties
PrimaryRADIATION ONCOLOGY
Education
MEDICAL UNIVERSITY OF SOUTH CAROLINA COLLEGE OF MEDICINE
Class of 1991
Research & Publications (20)
CD8+ T cell responses to a viral escape mutant epitope: active suppression via altered SHP-1 activity.
PMID 19201834·J Immunol·2009
7-preclinical
Early growth response gene 1 provides negative feedback to inhibit entry of progenitor cells into the thymus.
PMID 16585567·J Immunol·2006
7-preclinical
Control of recent thymic emigrant survival by positive selection signals and early growth response gene 1.
PMID 16081795·J Immunol·2005
7-preclinical
A phase II trial of pemetrexed and gemcitabine as first line therapy for poor performance status and/or elderly patients with stage IIIB/IV non-small cell lung cancer.
PMID 19167130·Lung Cancer·2009
3-trial
Role of palifermin in fluorouracil-based therapy for metastatic colorectal cancer.
PMID 18323563·J Clin Oncol·2008
8-other
Murine pregnancy leads to reduced proliferation of maternal thymocytes and decreased thymic emigration.
PMID 17250584·Immunology·2007
7-preclinical
Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy.
PMID 17075109·J Clin Oncol·2006
3-trial
An IL-7-dependent rebound in thymic T cell output contributes to the bone loss induced by estrogen deficiency.
PMID 16267136·Proc Natl Acad Sci U S A·2005
7-preclinical
Paclitaxel, carboplatin, and gemcitabine in the treatment of patients with advanced transitional cell carcinoma of the urothelium.
PMID 15856431·Cancer·2005
3-trial
Safety and pain palliation of zoledronic acid in patients with breast cancer, prostate cancer, or multiple myeloma who previously received bisphosphonate therapy.
PMID 15561812·Oncologist·2004
3-trial
Attitudes toward aging: a comparative analysis of young adults from the United States and Germany.
PMID 15176668·Int J Aging Hum Dev·2003
4-observational
Prostate specific antigen bounce after simultaneous irradiation for prostate cancer: the relationship to patient age.
PMID 14532794·J Urol·2003
8-other
Chemotherapy-induced nausea and vomiting: the importance of acute antiemetic control.
PMID 12697943·Oncologist·2003
6-review
Phase I study of paclitaxel and topotecan for the first-line treatment of extensive-stage small cell lung cancer.
PMID 12604734·Oncologist·2003
3-trial
Effect of recombination in the parent populations on the means and combining ability variances in hybrid populations of maize ( Zea mays L.).
PMID 12582860·Theor Appl Genet·2003
4-observational
Signal regulatory protein (SIRPalpha), a cellular ligand for CD47, regulates neutrophil transmigration.
PMID 11792697·J Biol Chem·2002
8-other
Reduced expression of junctional adhesion molecule and platelet/endothelial cell adhesion molecule-1 (CD31) at human vascular endothelial junctions by cytokines tumor necrosis factor-alpha plus interferon-gamma Does not reduce leukocyte transmigration under flow.
PMID 11733377·Am J Pathol·2001
8-other
Simultaneous irradiation for prostate cancer: intermediate results with modern techniques.
PMID 10953137·J Urol·2000
8-other
Human junction adhesion molecule regulates tight junction resealing in epithelia.
PMID 10852816·J Cell Sci·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1000 JOHNSON FERRY RD
ATLANTA, GA 30342 - Phone
- (404) 851-8000
Quick Facts
- NPI
- 1487638607
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 2
- Years in Practice
- 35
- Publications
- 20
Are you this provider?
Claim Your Profile